HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ernst Wagner Selected Research

Cyclophosphamide (Cytoxan)

4/2013Characterization of in vivo chemoresistant human hepatocellular carcinoma cells with transendothelial differentiation capacities.
2/2013A Comprehensive Gene Expression Analysis of Resistance Formation upon Metronomic Cyclophosphamide Therapy.
1/2012miR-200c sensitizes breast cancer cells to doxorubicin treatment by decreasing TrkB and Bmi1 expression.
5/2010In vivo chemoresistance of prostate cancer in metronomic cyclophosphamide therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ernst Wagner Research Topics

Disease

139Neoplasms (Cancer)
04/2024 - 04/2002
18Breast Neoplasms (Breast Cancer)
04/2024 - 01/2006
18Hepatocellular Carcinoma (Hepatoma)
10/2020 - 11/2002
13Neuroblastoma
06/2023 - 08/2002
10Glioblastoma (Glioblastoma Multiforme)
09/2023 - 01/2006
10Carcinoma (Carcinomatosis)
06/2023 - 02/2006
9Liver Neoplasms (Liver Cancer)
01/2019 - 04/2011
9Neoplasm Metastasis (Metastasis)
11/2017 - 04/2004
8Glioma (Gliomas)
10/2023 - 12/2006
5Prostatic Neoplasms (Prostate Cancer)
02/2015 - 05/2010
4Hyperthermia
01/2021 - 05/2006
4Human Influenza (Influenza)
03/2016 - 11/2002
3Inborn Genetic Diseases (Disease, Hereditary)
01/2023 - 07/2011
3Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 02/2006
3Leukemia
01/2018 - 01/2012
3Colonic Neoplasms (Colon Cancer)
11/2017 - 01/2007
2COVID-19
01/2023 - 01/2022
2Infections
01/2023 - 02/2013
2Hypoxia (Hypoxemia)
11/2018 - 08/2016
2Adenocarcinoma
05/2017 - 01/2006
2Melanoma (Melanoma, Malignant)
01/2013 - 08/2002
2Rupture
01/2008 - 01/2005

Drug/Important Bio-Agent (IBA)

27LigandsIBA
10/2023 - 11/2002
26Peptides (Polypeptides)IBA
01/2024 - 11/2002
26Small Interfering RNA (siRNA)IBA
10/2021 - 11/2006
23sodium-iodide symporter (sodium iodide symporter)IBA
09/2023 - 10/2009
21DNA (Deoxyribonucleic Acid)IBA
11/2023 - 04/2002
18Proteins (Proteins, Gene)FDA Link
04/2024 - 11/2005
18ErbB Receptors (EGF Receptor)IBA
12/2022 - 11/2002
17PolymersIBA
04/2024 - 01/2003
17PolyethyleneimineIBA
01/2019 - 08/2002
14Nucleic AcidsIBA
01/2023 - 04/2004
14Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric
12/2017 - 11/2002
13LuciferasesIBA
06/2023 - 11/2002
10Messenger RNA (mRNA)IBA
06/2023 - 04/2013
10IodidesIBA
12/2022 - 04/2011
9Doxorubicin (Adriamycin)FDA LinkGeneric
11/2022 - 01/2012
9Epidermal Growth Factor (EGF)IBA
01/2018 - 11/2002
8Folic Acid (Vitamin M)FDA LinkGeneric
01/2023 - 03/2016
8Transferrin (beta 2 Transferrin)IBA
06/2022 - 08/2002
7CytokinesIBA
01/2024 - 01/2006
7Therapeutic UsesIBA
12/2022 - 06/2007
7Radioisotopes (Radionuclides)IBA
05/2022 - 10/2009
6salinomycinIBA
08/2016 - 12/2012
6Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
02/2013 - 08/2002
5pretubulysinIBA
10/2019 - 10/2017
5Dendrimers (Dendrons)IBA
11/2013 - 12/2008
4MicroRNAs (MicroRNA)IBA
11/2022 - 01/2012
4Cyclophosphamide (Cytoxan)FDA LinkGeneric
04/2013 - 05/2010
4RNA (Ribonucleic Acid)IBA
10/2011 - 12/2006
4Double-Stranded RNA (RNA, Double Stranded)IBA
10/2011 - 01/2006
3VaccinesIBA
11/2023 - 01/2020
3LipidsIBA
01/2023 - 03/2005
3AmidesIBA
01/2023 - 08/2014
3Transferrin Receptors (Transferrin Receptor)IBA
12/2022 - 01/2011
3AntigensIBA
01/2022 - 04/2004
3ChemokinesIBA
12/2021 - 03/2011
3Methotrexate (Mexate)FDA LinkGeneric
01/2019 - 10/2017
3CarbonIBA
01/2018 - 08/2014
3Pancreatic Ribonuclease (Ribonuclease A)IBA
08/2017 - 01/2016
3Cysteine (L-Cysteine)FDA Link
01/2017 - 04/2012
3PAMAM StarburstIBA
08/2015 - 08/2010
3Adenosine Triphosphatases (ATPase)IBA
05/2014 - 11/2012
3poly(ethylene glycol)-co-poly(ethyleneimine)IBA
02/2014 - 01/2003
3CytosineIBA
03/2011 - 01/2006
2InterleukinsIBA
01/2024 - 01/2022
2Glutathione (Reduced Glutathione)IBA
11/2022 - 08/2013
2Chimeric Antigen ReceptorsIBA
01/2022 - 12/2021
2Neoplasm Antigens (Tumor Antigens)IBA
12/2021 - 01/2020
2Phenobarbital (Luminal)FDA Link
02/2019 - 08/2016
2Selective Estrogen Receptor Modulators (SERM)IBA
02/2019 - 08/2016
2Adenosine Triphosphate (ATP)IBA
11/2018 - 11/2012
2ProteomeIBA
01/2018 - 11/2007
2Tyrosine (L-Tyrosine)FDA Link
10/2017 - 01/2017
2BuffersIBA
10/2017 - 02/2014
2perchlorateIBA
05/2017 - 08/2016
2B6 peptideIBA
05/2017 - 09/2015
2Proto-Oncogene Proteins c-metIBA
01/2016 - 03/2015
2Chemokine CCL5IBA
04/2015 - 03/2013
2Poly I-CIBA
08/2014 - 04/2011
2Cathepsin BIBA
05/2014 - 05/2010
2Proton Pumps (Proton Pump)IBA
04/2014 - 11/2012
2Vacuolar Proton-Translocating ATPases (V-Type ATPase)IBA
04/2014 - 01/2005
2monomethoxypolyethylene glycol (MPEG)IBA
02/2014 - 08/2013
2Coloring Agents (Dyes)IBA
02/2014 - 04/2013
2Poly(amidoamine)IBA
08/2013 - 02/2013
2Drug CarriersIBA
02/2013 - 11/2009
2Annexin A3IBA
02/2013 - 05/2010
2Dextrans (Dextran)FDA Link
05/2011 - 01/2005
2Apoptosis Inducing FactorIBA
12/2008 - 11/2005

Therapy/Procedure

66Therapeutics
04/2024 - 04/2004
14Precision Medicine
09/2023 - 08/2013
8Intravenous Administration
06/2023 - 08/2008
6Intravenous Injections
11/2017 - 11/2002
5Immunotherapy
11/2023 - 11/2002
5Drug Therapy (Chemotherapy)
04/2017 - 07/2011
4Radiotherapy
01/2020 - 11/2018
4Gamma Cameras (Gamma Camera)
12/2017 - 12/2011
2Induced Hyperthermia (Thermotherapy)
01/2020 - 11/2008
2Injections
03/2018 - 02/2014